Forlong Biotechnology
FB
About
Forlong Biotechnology is a clinical-stage biotechnology company focused on developing transformative cytokine therapies for patients with severe unmet medical needs. The company recently completed a Series Pre-B financing round of RMB 120 million (approximately USD 17.5 million).
Competitors & alternatives (6)
Forlong Biotechnology alternatives 
Key facts
At-a-glance profile data
- Website
- forlongbio.com
- Headquarters
- Shanghai, China
- Total funding
- $18M (Series Pre-B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Sept 2023 | Series Pre-B | $18M | - |
Add first review
Frequently asked
How much funding has Forlong Biotechnology raised?
Forlong Biotechnology has raised a total of $18M in funding. The most recent round on record is Series Pre-B.
What is Forlong Biotechnology's current status?
Forlong Biotechnology's current operating status is: Inactive.